Keyphrases
Transgenic Mice
100%
Diabetic
100%
Soluble Form
100%
Barrier Breakdown
100%
Blood-retinal Barrier
100%
Receptor for Advanced Glycation End Products
100%
Leukostasis
100%
Retina
50%
Advanced Glycation End Products
50%
Intercellular Adhesion molecule-1 (ICAM-1)
50%
Diabetic Retinopathy
50%
Retinal Vessels
33%
Diabetes
16%
Bioactivity
16%
Consecutive Days
16%
Streptozotocin
16%
Systemic Administration
16%
Clinical Symptoms
16%
Serum Albumin
16%
Mouse Serum
16%
Flk-1
16%
Diabetic Retinopathy Treatment
16%
Experimental Diabetes
16%
Pharmacology, Toxicology and Pharmaceutical Science
Advanced Glycation End Product Receptor
100%
Leukostasis
100%
Transgenic Mouse
85%
Diabetic Retinopathy
57%
Advanced Glycation End Product
42%
Intercellular Adhesion Molecule 1
42%
Experimental Diabetes Mellitus
14%
Neuroscience
Advanced Glycation End Product Receptor
100%
Blood Retina Barrier
100%
Diabetic Retinopathy
66%
Intercellular Adhesion Molecule 1
50%
Advanced Glycation End Product
50%
Serum Albumin
16%